Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 434 entries
View as:

Neuropsychological and Behavioral Testing in Younger Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00772200 Org: User:
Start: 02/27/09 End: - Due: -

Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00002785 Org: User:
Start: 07/31/96 End: 03/31/07 Due: 03/31/08

Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00077207 Org: User:
Start: 07/31/04 End: 12/31/13 Due: 12/31/14

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

Phase: N/A Priority: Normal
NCT ID: NCT05504291 Org: User:
Start: 11/04/22 End: 12/31/26 Due: 12/31/27

Biomarker Study in Tissue Samples From Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01232842 Org: User:
Start: 10/31/10 End: - Due: -

Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531

Phase: N/A Priority: Normal
NCT ID: NCT01407757 Org: User:
Start: 07/31/11 End: - Due: -

Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01503086 Org: User:
Start: 07/30/14 End: 12/31/25 Due: 12/31/26

Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00003593 Org: User:
Start: 06/30/99 End: 04/30/12 Due: 04/30/13

Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03817398 Org: User:
Start: 11/08/19 End: 06/30/26 Due: 06/30/27

Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00002610 Org: User:
Start: 01/31/96 End: 02/28/06 Due: 02/28/07

Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT00028899 Org: User:
Start: 07/31/02 End: 03/31/12 Due: 03/31/13

Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421

Phase: N/A Priority: Normal
NCT ID: NCT01035307 Org: User:
Start: 10/31/09 End: - Due: -

Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00061893 Org: User:
Start: 04/30/04 End: 12/31/13 Due: 12/31/14

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01154816 Org: User:
Start: 02/28/11 End: 06/30/19 Due: 06/30/20

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT05711667 Org: User:
Start: 05/20/24 End: 06/01/28 Due: 06/01/29

Comparison of Laboratory Test Results of Minimal-Residual Disease in Samples From Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01498302 Org: User:
Start: 02/29/12 End: - Due: -

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06247787 Org: User:
Start: 02/04/25 End: 06/30/26 Due: 06/30/27

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04870944 Org: User:
Start: 01/28/22 End: 12/31/26 Due: 12/31/27

A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home

Phase: N/A Priority: Normal
NCT ID: NCT06639958 Org: User:
Start: 12/04/24 End: 03/03/27 Due: 03/03/28

Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT02717507 Org: User:
Start: 04/04/16 End: 03/31/25 Due: 03/31/26

High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma

Phase: N/A Priority: Normal
NCT ID: NCT00354744 Org: User:
Start: 07/31/06 End: 06/30/19 Due: 06/30/20

Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003811 Org: User:
Start: 04/30/00 End: 09/30/07 Due: 09/30/08

Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00003783 Org: User:
Start: 03/31/99 End: 03/31/07 Due: 03/31/08

Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00411281 Org: User:
Start: 03/31/06 End: 11/30/07 Due: 11/30/08

Biomarkers in Samples From Younger Patients With Wilms Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01493817 Org: User:
Start: 12/31/11 End: - Due: -